In vitro evaluation of the ability of platelet-rich plasma to seal an iatrogenic fetal membrane defect

Prenatal Diagnosis

Volumn 29, Issue 6, 2009, Pages 620-625

  Lewi, L ^a   Liekens, D ^a   Heyns, L ^a   Poliard, E ^a   Beutels, E ^a   Deprest, J ^c   Hoylaerts, M F ^b  

^a Faculty of Medicine   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Invasive fetal therapy; Platelet rich plasma; PROM; Ruptured membranes

Indexed keywords

AMNION; AMNION FLUID; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CHORION; EXPLANT; FETUS; FETUS MEMBRANE DEFECT; HUMAN; HUMAN TISSUE; IATROGENIC DISEASE; IN VITRO STUDY; MEMBRANE DAMAGE; MONOLAYER CULTURE; PRIORITY JOURNAL; THROMBOCYTE RICH PLASMA;

CELL MOVEMENT; EXTRAEMBRYONIC MEMBRANES; HUMANS; ORGAN CULTURE TECHNIQUES; PLATELET-RICH PLASMA; TISSUE ADHESIVES; WOUND HEALING;

EID: 67049171392     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2249     Document Type: Article

References (20)

1. Cobo T, Borrell A, Fortuny A, et al. 2007. Treatment with amniopatch of premature rupture of membranes after first-trimester chorionic villus sampling. Prenat Diagn 27: 1024-1027.
2. Contino B, Armellino F, Brokaj L, Patroncini S. 2004. Amniopatch, a repairing technique for premature rupture of amniotic membranes in second trimester. Acta Biomed 75(Suppl. 1): 27-30.
3. Deprest J, Jani J, Lewi L, et al. 2006. Fetoscopic surgery: encouraged by clinical experience and boosted by instrument innovation. Semin Fetal Neonatal Med 11: 398-412.
4. Devlieger R, Verbist L, Pijnenborg R, Deprest JA. 2002. Growth factors in fetal membrane healing: evaluation using confluent cultures of amnion derived epithelial WISH cells. J Soc Gynecol Investig 9(Suppl.): 219A.
5. Eppley BL, Pietrzak WS, Blanton M. 2006. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 18: 147e-159e.
6. Estellés A, Gilabert J, Andrés C, España F, Aznar J. 1990. Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy. Thromb Haemost 64: 281-285.
7. Gratacos E, Sanin-Blair J, Lewi L, et al. 2006. An histological study of fetoscopic membrane defects to document membrane healing. Placenta 27: 452-456.
8. Gratacos E, Wu J, Yesildaglar N, Devlieger R, Pijnenborg R, Deprest JA. 2000. Successful sealing of fetoscopic access sites with collagen plugs in the rabbit model. Am J Obstet Gynecol 182(1 Pt 1): 142-146.
9. Lewi L, Van Schoubroeck D, Van Ranst M, et al. 2004. Successful patching of iatrogenic rupture of the fetal membrane. Placenta 25: 352-356.
10. Liekens D, Lewi L, Jani J, et al. 2008. Enrichment of collagen plugs with platelets and amniotic fluid cells increases cell proliferation in sealed iatrogenic membrane defects in the foetal rabbit model. Prenat Diagn 28(6): 503-507.
11. Louis-Sylvestre C, Rand JH, Gordon RE, Salafia CM, Berkowitz RL. 1998. In vitro studies of the interactions between platelets and amniotic membranes: a potential treatment for preterm premature rupture of the membranes. Am J Obstet Gynecol 178: 287-293.
12. Luks FI, Deprest JA, Peers KH, Steegers EA, Van Der Wildt B. 1999. Gelatin sponge plug to seal fetoscopic port sites: technique in ovine and primate models. Am J Obstet Gynecol 181: 995-996.
13. Millar LK, Reiny R, Yamamoto SY, Okazaki K, Webster L, Bryant-Greenwood GD. 2003. Relaxin causes proliferation of human amniotic epithelium by stimulation of insulin-like growth factor-II. Am J Obstet Gynecol 188: 234-241.
14. Nong Z, Hoylaerts M, Van Pelt N, Collen D, Janssens S. 1997. Nitric oxide inhalation inhibits platelet aggregation and platelet-mediated pulmonary thrombosis in rats. Circ Res 81: 865-869.
15. Quintero RA, Morales WJ, Allen M, Bornick PW, Arroyo J, LeParc G. 1999. Treatment of iatrogenic previable premature rupture of membranes with intra-amniotic injection of platelets and cryoprecipitate (amniopatch): preliminary experience. Am J Obstet Gynecol 181: 744-749.
16. Reddy UM, Shah SS, Nemiroff RL, et al. 2001. In vitro sealing of punctured fetal membranes: potential treatment for midtrimester premature rupture of membranes. Am J Obstet Gynecol 185: 1090-1093.
17. Scott DM, Griffin B, Pepper DS, Barnes MJ. 1981. The binding of purified factor VIII/von Willebrand factor to collagens of differing type and form. Thromb Res 24: 467-472.
18. Sipurzynski-Budrass S, Marcher S, Haeusler M, Lanzer G. 2006. Successful treatment of premature rupture of membranes after genetic amniocentesis by intra-amniotic injection of platelets and cryoprecipitate (amniopatch): a case report. Vox Sang 91: 88-90.
19. Terada S, Matsuura K, Enosawa S, et al. 2000. Inducing proliferation of human amniotic epithelial (HAE) cells for cell therapy. Cell Transplant 9: 701-704.
20. Watanabe T, Araki M, Mimuro J, Tamada T, Sakata Y. 1993. Fibrinolytic components in fetal membranes and amniotic fluid. Am J Obstet Gynecol 168: 1283-1289.